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Abstract 
Introduction: We evaluated the radiopacity and the antibacterial properties of various 
concentrations of double antibiotic paste (DAP) containing barium sulfate (BaSO4) or zirconium 
oxide (ZrO2) radiopaque agents for both direct and residual antibacterial effects. Methods: The 
radiopacity of 1, 10 and 25 mg/mL of DAP containing 30% (w/v) of BaSO4 or ZrO2, DAP-free 
radiopaque pastes and commercially available radiopaque calcium hydroxide (Ca(OH)2) were 
evaluated according to ISO 6876/2001 with slight modifications (n=6 per group). In order to test 
for direct antibacterial effects dentin samples (n=70) infected anaerobically for 3 weeks with 
bacterial biofilms obtained from root canals of an immature tooth with pulpal necrosis were 
treated with similar experimental pastes or received no treatment (n=7). After one week, the 
pastes were rinsed-off and biofilm disruption assays were conducted. In order to demonstrate 
residual effects sterile dentin samples (n=70) were pretreated for 1 week with the same pastes 
(n=7). The pastes were rinsed off, samples were immersed in PBS for 24 hours and infected 
anaerobically with the same bacterial biofilm mentioned earlier for 3 weeks before conducting 
biofilm disruption assays. Sterile dentin blocks were used in both antibacterial analyses as 
negative control groups (n=14). Wilcoxon Rank Sum tests were used for statistical analyses. 
Results: No tested concentrations of BrSO4-DAP and ZrO2-DAP demonstrated significant 
differences from Ca(OH)2 in radiopacity. However, all tested concentrations of BrSO4-DAP and 
ZrO2-DAP as well as Ca(OH)2 exhibited significant direct antibacterial effects. ZrO2-DAP at 1 
mg/mL and Ca(OH)2 did not demonstrate significant residual antibacterial effects.  Conclusions: 
BrSO4-DAP at 1 mg/mL provided significantly superior residual antibacterial effects and 
comparable radiopacity to the commercially available Ca(OH)2. 
Keywords: Biofilms, Endodontic regeneration, Double antibiotic paste, Barium sulfate, 
Immature tooth, Zirconium oxide.  
Introduction 
The introduction of endodontic regeneration procedures has rejuvenated the use of 
various antibiotic mixtures as intracanal medicaments. Recent in vitro studies have found that 
intracanal antibiotic medicaments such as triple (TAP) or double (DAP) antibiotic paste may 
offer superior root canal disinfection in comparison to traditional calcium hydroxide (Ca(OH)2) 
intracanal medicament (1, 2). However, unlike Ca(OH)2, clinically used concentrations (500-
1000 mg/mL) of these antibiotic mixtures were found to exert cytotoxic effects on stem cells 
from apical papillae (3, 4), dental pulp stem cells (5), and dental pulp fibroblast (6). Therefore, 
evidence-based recommendations suggested the use of Ca(OH)2 or low concentrations on DAP 
or TAP ranging between 0.1-1 mg/mL in an attempt to provide an efficient antimicrobial 
medicament without jeopardizing the fate of  pluripotent stem cells within the root canal system 
(7). 
The inability of these antibiotic medicaments to be visualized radiographically may offer 
a challenging aspect to clinicians in term of insuring the satisfactory application of the 
medicaments. Indeed, the use of radiopaque intracanal medicaments can be of particular 
importance during endodontic regeneration due to the presence of large blunder buss apices of 
immature teeth with necrotic pulps. Therefore, over or under application of non-radiopaque 
antibiotic medicaments can easily go unnoticed, which may lead to suboptimal root canal 
disinfection during regenerative endodontics. Radiopaque components are usually added to 
endodontic materials (cements, pastes, sealers, and obturating materials) to provide radiopacity 
that can help in determining the exact location of the root canal material in the root canal system 
as well as improving the ability of the material to localize anatomical structures within the root 
canal system. The radiocontrast agents commonly used in endodontic materials are insoluble 
salts of heavy metals such as barium, zirconium and bismuth. The aim of this study was to 
introduce two types of radiopaque DAP and investigate the direct and residual antibacterial 
effects of these radiopaque antibiotic medicaments.  
Materials and methods 
Preparation of radiopaque DAP 
Two radiopaque materials, namely barium sulfate (BaSO4) and zirconium oxide (ZrO2) 
were selected for this study. Various concentrations of DAP containing the two radiopaque 
agents were prepared as described in previous studies (8, 9) with a modification to incorporate 
the radiopaque materials. In summary, 10, 100, and 250 mg of equal portions of metronidazole 
and ciprofloxacin (Champs Pharmacy, San Antonio, TX) were independently dissolved in 10 mL 
of sterile water to form 1,10 and 25 mg/mL of DAP solutions, respectively. Then, 3 g of barium 
sulfate (Reagent Plus, Sigma-Aldrich, St. Louis, MO) or zirconium oxide (5 um powder; Sigma) 
was gradually incorporated into each DAP solution with vigorous stirring to form a 30% 
radiopaque DAP slurry composed of 30% (w/v) of each radiopaque material. Thereafter, 0.7 g of 
methylcellulose powder (Methocel 60 HG, Sigma-Aldrich, St. Louis, MO) was gradually 
dissolved into each DAP slurry at room temperature to create a  pasty consistency of DAP. 
Finally, each radiopaque DAP was centrifuged for 15 minutes at 7000 rpm to form a bubble-free 
homogenous injectable paste with 1, 10 and 25 mg/mL of DAP (BrSO4-DAP or ZrO2-DAP). 
Furthermore, DAP-free radiopaque placebo pastes were also prepared as described earlier. The 
percentage of radiopaque agents (30% w/v) was selected based on pilot studies that examined 
20-40% of both radiopaque agents in 5% increments compared to a commercially available 
radiopaque Ca(OH)2 intracanal medicament (UltraCal XS, Ultradent, South Jordan, UT).   
Assessment of radiopacity  
The radiopacity of various concentrations of BrSO4-DAP (1, 10, 25 mg/mL), ZrO2-DAP 
(1, 10, 25 mg/mL), the two DAP-free placebo pastes, and the commercially available radiopaque 
calcium hydroxide medicament (UltraCal) were evaluated according to ISO 6876:2012 (10) with 
slight modifications. Briefly, disk-shaped plastic molds (internal diameter of 1 and 10 mm in 
thickness) were positioned on occlusal radiograph films (Insight-Kodak Comp, Rochester, NY) 
and filled with the tested pastes (n=6). Radiographs of the pastes along with an aluminum step 
wedge with variable thickness (from 1 to 5 mm, in 1 mm increments) were taken using a single-
phase dental X-ray unit (Heliodent DS, Sirona Dental, Inc., Charlotte, NC) with 65 kV and a 
distance of 30 cm. The radiographic films were processed using an automatic processor. Finally, 
the densities of the image of the pastes were compared to that of the different thickness of the 
aluminum step wedge using a densitometer (X-Rite, model 301, X-Rite, Grand Rapids, MI) and 
the radiopacity equivalent of each sample was expressed in millimeter of aluminum (mm Al). 
 Dentin sample preparation 
Extracted intact human teeth were used to prepare radicular dentin samples (4×4×2 mm3) 
according to a standardized protocol. Briefly, a low speed diamond saw under constant water 
irrigation was used to obtain dentin samples with the standardized dimensions. The samples were 
polished sequentially using abrasive papers (500–2400 grit; Struers, Cleveland, OH) and a Roto 
Pol 31 polishing unit (Struers). The samples were sequentially irrigated with 1.5% NaOCl, 
double distilled water and 17% EDTA (4 minutes each) to open dentin tubules and remove the 
smear layer (11). All samples were gas sterilized using ethylene oxide and maintained at 100% 
humidity and 4˚C until used.  
 
Collection of bacterial isolate 
An institutional review board approval was obtained (IRB # 1510640949) to collect a 
clinical bacterial isolate from an infected root canal of an immatue tooth that was indicated for 
endodontic regenerative treatment. The selected subject was healthy and had not used antibiotics 
for 6 months. Both the subject and his parent signed an informed assent and consent before 
collection of the bacterial isolate. The bacterial isolate was obtained according to a standardized 
protocol detailed in previous studies (2, 12), anaerobically incubated in brain heart infusion broth 
supplemented with 5 g/L of yeast extract (BHI-YE) at 37˚C for 48 hours, and frozen at −80˚C 
until used. 
Direct antibacterial effects of radiopaque DAP 
Sterile dentin samples (n=70) were individually inserted into wells of sterile 96-well 
microtiter plates (FisherBrand, Fischer Scientific) with the pulpal sides oriented outward. The 
dentin samples were infected with 10 µL of an overnight culture (1 × 105 CFU/mL) of the 
biofilm bacteria obtained from an immature tooth with pulpal necrosis and 190 µL of fresh BHI-
YE added. The infected dentin samples were incubated for 3 weeks anaerobically with weekly 
replacement of BHI-YE growth media. The weekly replacement of growth media was aimed to 
maintain the original taxa of the clinical isolates by limiting the nutritional supply as 
recommended in previous publications (13, 14). Three additional dentin samples were infected 
with the same biofilm bacteria and viewed under scanning electron microscopy (JEOL 7800F, 
Peabody, MA). 
After three weeks, the infected dentin samples were randomized into 10 experimental 
groups (n=7) and treated for one week at 37˚C with BrSO4-DAP (1, 10, 25 mg/mL), ZrO2-DAP 
(1, 10, 25 mg/mL), BrSO4-Placebo, ZrO2-Placebo, Ca(OH)2 (UltraCal) or sterile water. All 
infected dentin samples were treated for 1 week at 37°C and 100% humidity. A bacteria-free 
sterile dentin group (n=7) was also utilized in this experiment as a negative group to exclude the 
presence of bacterial contamination though the course of the experiment. The dentin samples in 
the negative control received fresh BHI-YE and was incubated anaerobically with the rest of the 
samples for 3 weeks with weekly replacement of BHI-YE.  
After treatment, each sample was gently irrigated with 3 mL of sterile water for 1 min to 
rinse off the treatment pastes and each dentin sample was subjected to a biofilm disruption assay 
as described in earlier studies (15, 16). Briefly, each dentin sample was placed into a sterile test 
tube containing 2 mL of sterile water. Each sample was sonicated and vortexed (30 s each) to 
dislodge the biofilms. The obtained biofilms were diluted, spiral plated on blood agar plates, 
incubated anaerobically for 24 h, and CFUs/mL were counted using an automated colony counter 
(Synbiosis, Inc, Frederick, MD, USA). 
Residual antibacterial effects of radiopaque DAP 
Additional sterilized dentin samples (70) were placed in 96-well microtiter plates in order 
to be  pretreated for 1 week with the same ten experimental groups described earlier (n=10). 
After treatment, the pastes were washed off from the dentin samples using sterile saline followed 
by a 1 min irrigation with 5 mL of 17% EDTA. Dentin samples were independently immersed in 
200 mL of sterile phosphate buffered saline (PBS) and stored at 37ºC for 24 h. After immersion, 
dentin samples were infected with an overnight culture of the biofilm bacteria obtained from the 
immature tooth with pulpal necrosis discussed earlier (n=7). The bacterial biofilms were grown 
anaerobically for 3 weeks as described earlier. Additional non-infected sterile dentin samples 
(n=7) were used as a negative control throughout this experiment. After the incubation period, all 
samples were subjected to biofilm disruption assays and CFUs/mL were quantified. 
Statistical analyses   
Wilcoxon Rank Sum tests were used to compare the radiopacity, and direct and residual 
antibacterial effects of all experimental groups (α=0.05). 
Results 
Assessment of radiopacity 
Both BrSO4-DAP and ZrO2-DAP at the three tested concentrations (1, 10, 25 mg/mL) did 
not demonstrate a significant difference from calcium hydroxide (the commercial control) in 
radiopacity (Figure 1). However, the ZrO2-Placebo samples demonstrated significantly higher 
(P<0.01) radiopacity than the BrSO4-DAP (all concentrations), Ca(OH)2 and ZrO2-DAP at 25 
mg/mL groups. ZrO2-DAP at 1, 10 and 25 mg/mL exhibited significantly higher radiopacity than 
BrSO4-DAP at 1, 10 and 25 mg/mL, respectively (P<0.01).    
Assessment of direct antibacterial effects 
BrSO4-DAP and ZrO2-DAP at the three tested concentrations (1, 10, 25 mg/mL) as well 
as Ca(OH)2 demonstrated significant direct antibacterial effects in comparison to placebo pastes 
and the no treatment control groups (P<0.001) (Table 1). Furthermore, BrSO4-DAP at all tested 
concentrations and ZrO2-DAP at 10 and 25 mg/mL demonstrated significantly higher 
antibacterial effects in comparisons to BrSO4-DAP at 1 mg/mL (P<0.01). No bacterial growth 
was detected in the negative (sterile) control group. SEM images taken at various magnifications 
demonstrated thick heterogenic biofilm structures covering most of the pulpal surface of the 
dentin (Figures 2A and 2B).    
Assessment of residual antibacterial effects 
BrSO4-DAP at all tested concentrations as well as ZrO2-DAP at 10 and 25 mg/mL 
demonstrated significantly higher residual antibacterial effects in comparison to ZrO2-DAP at 1 
mg/mL, Ca(OH)2, placebo pastes and the no treatment control groups (P<0.01) (Table 1). 
However, no significant differences were found between ZrO2-DAP at 1 mg/mL, Ca(OH)2, 
placebo pastes and the no treatment control groups. Additionally, the negative (sterile) control 
group did not demonstrate any bacterial growth.   
Discussion 
Commercially available antibiotic intracanal medicaments such as Ledermix and 
Odontopaste are available. However, these medicaments contain relatively high concentrations 
of antibiotic and are not radiopaque, which limits their use. Recent studies introduced an 
injectable controlled low concentration of DAP loaded into a biocompatible hydrogel (2, 15). 
However, one of the limitations of these injectable medication is their lack of radiopaque 
properties. Since there is no ISO standard for testing intracanal medicaments, the radiopacity 
testing protocol used in the current study was adapted from the ISO 6876; 2012 standards 
designed for dental root canal sealing materials with a slight modification. The tested 
medicaments in our study were radiographed immediately after their application into the plastic 
molds rather than waiting for 24 h as recommended by ISO since these medicaments are not 
expected to set like root canal sealers.   
The current study introduced two different types of radiopaque DAP with controlled 
concentrations using FDA approved radiocontrast agents (BrSO4 and ZrO2). BrSO4 is a 
commonly used radiopaque material in Ca(OH)2-based root canal medicaments and zinc oxide-
eugenol-based root canal sealers. ZrO2 is also a commonly used radiopaque agent in commercial 
available bioceramic root canal sealers/cements such as Endosquence BC sealers as well as in 
Biodentine. Furthermore, both radiopaque materials were suggested to be biocompatible (17, 18) 
with minimum discoloration potential (19, 20). The current study demonstrated that both ZrO2-
DAP and BrSO4-DAP at all tested concentrations did not significantly different from Ca(OH)2 
(UltralCal). However, the tested concentrations of ZrO2-DAP (1, 10 and 25 mg/mL) 
demonstrated significantly higher radiopacity than the similarly tested concentrations of BrSO4-
DAP. The commercially available radiopaque Ca(OH)2 was used in this study because it is one 
of the most commonly used intracanal medicaments in the United States and has been used in 
multiple endodontic regeneration studies (3, 4, 9).  
Our study demonstrated that ZrO2-DAP and BrSO4-DAP as low as 1 mg/mL caused 
significant reduction in bacterial biofilm in comparison to the radiopaque DAP-free placebo 
pastes. This indicates that the addition of these radiopaque agents at 30% (w/v) did not interfere 
with the direct antibacterial properties of DAP at the tested concentrations (1-25 mg/mL). This 
agreed with recent studies which found significant direct antibacterial effects of 1 mg/mL of non-
radiopaque DAP against bacterial biofilm obtained from clinical isolates (2) as well as bacterial 
biofilm of Enterococcus faecalis (15). Our study also demonstrated that BrSO4-DAP at 1 mg/mL 
exhibited significantly higher direct antibacterial effects than ZrO2-DAP at 1 mg/mL. It is worth 
noting that 1 mg/mL of DAP was selected in this study as the minimum tested concentration 
because it is the currently recommended concentration of intracanal antibiotic medicaments for 
endodontic regeneration (7).  
Our study also found that BrSO4-DAP at 1 mg/mL exhibited significant residual 
antibacterial effects. On the other hand, ZrO2-DAP at 1 mg/mL as well as Ca(OH)2 did not 
exhibit any significant residual antibacterial effects. This might suggest that ZrO2 can interfere 
with residual antibacterial effects of the 1 mg/mL DAP. Therefore, higher concentration of DAP 
may be needed if ZrO2 is to be used as radiopaque agent as ZrO2-DAP at 10 mg/mL 
demonstrated significant residual antibacterial effects. The collective finding of direct and 
residual antibacterial experiments conducted in this study indicates that BrSO4-DAP exhibited 
significantly superior antibacterial properties than ZrO2-DAP at 1 mg/mL. One of the main 
advantages of using antibiotic-containing intracanal medicaments over Ca(OH)2 during 
regenerative endodontic is the residual ability of these antibiotics to bind to dentin matrix and 
extend the antimicrobial properties within the root canal system even after their removal (1, 2). 
Recent in vitro studies, as in this study, have found that Ca(OH)2 cannot provide any residual 
antibacterial properties after its removal from radicular dentin (1, 2). These laboratory findings 
are in support of clinical studies that found bacterial regrowth after removal of a Ca(OH)2 
intracanal medicament (21, 22).  
In the current study, a clinical isolate obtained from an immature tooth with necrotic pulp 
was used to establish the bacterial biofilm in an attempt to create a more resistant in vitro model. 
Bacterial biofilms from immature teeth were found to be more resistant to antimicrobials 
compared to bacterial biofilms from mature teeth (2, 23). Collectively, our study indicates that 
BrSO4-DAP at 1 mg/mL offered significantly superior residual antibacterial properties and 
comparable radiopacity to the commercially available radiopaque Ca(OH)2 medicament. 
Additionally, ZrO2-DAP at 1 mg/mL demonstrated comparable radiopacity and antibacterial 
characteristics. Further studies are warranted to determine the biocompatibility of the suggested 
radiopaque DAP medicaments. 
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Table 1. The direct and residual antibacterial effects of the different radiopaque antimicrobials 
against bacterial biofilms from immature teeth with pulpal necrosis represented as the mean (SE) 
of the log CFU/mL 
  
Different upper-case letters indicate significant differences between the different types of 
treatment within each experiment.  
 
Type of treatment 
Direct 
antibacterial 
effects 
 Mean log10 (SE) 
Number of 
positive 
samples 
Residual 
antibacterial 
effects                    
Mean log10 (SE) 
Number of 
positive 
samples 
BrSO4-DAP 
25mg/mL 0.00 (0)A 0/7 0.00 (0)A 0/7 
BrSO4-DAP 
10mg/mL 0.00 (0)A 0/7 0.00 (0)A 0/7 
BrSO4-DAP 1mg/mL 0.00 (0)A 0/7 0.00 (0)A 0/7 
ZrO2-DAP 25mg/mL  0.00 (0)A 0/7 0.00 (0)A 0/7 
ZrO2-DAP 10mg/mL 0.00 (0)A 0/7 0.00 (0)A 0/7 
ZrO2-DAP 1mg/mL 1.66 (0.61)B 4/7 5.26 (0.20)B 7/7 
Ca(OH)2 0.00 (0)A 0/7 5.48 (0.56)B 7/7 
BrSO4-Placebo 6.18 (0.06)C 7/7 5.33 (0.27)B 7/7 
ZrO2-Placebo 6.17 (0.07)C 7/7 5.30 (0.33)B 7/7 
Positive control  6.20 (0.03)C 7/7 5.55 (0.25)B 7/7 
Negative control 0.00 (0)A 0/7 0.00 (0)A 0/7 
Figure 1. The radiopacity of different radiopaque antibacterial medicaments represented 
as the mean (±SE) of mm Al. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Scanning electron microscopic images under low (A) and high (B) magnifications of 
established 3-week old bacterial biofilm on dentin formed by bacteria obtained from an 
infected root canal of an immature tooth with necrotic pulp.       
   
